Poultry Medicine Market Size, Share and Growth Outlook 2026: By Product Type (Vaccines, Pharmaceuticals / Drugs, Medicative Feed Additives), By Animal Type, By Disease Indication, By Route of Administration, Companies to 2034.
The global Poultry Medicine Market size is forecast to increase from $5.57 Billion in 2026 to $8.72 Billion in 2034 at a CAGR of 5.77% between 2026 and 2034.
The Poultry Medicine market report provides detailed analysis and outlook of Poultry Medicine segments including By Product Type (Vaccines, Pharmaceuticals / Drugs, Medicative Feed Additives), By Animal Type (Chickens, Turkeys, Ducks and Other Poultry Species), By Disease Indication (Viral Diseases, Bacterial Diseases, Parasitic/Fungal Diseases ), By Route of Administration (Oral, Parenteral, Topical / Spray / In-Ovo) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.
Poultry Medicine Industry Overview
Advanced Vaccination Platforms, Hatchery Automation, and Nucleic Acid Technologies are Reshaping the Poultry Medicine Industry
The poultry medicine industry is undergoing rapid technological transformation as producers, veterinary pharmaceutical companies, and regulatory agencies intensify efforts to combat emerging infectious diseases, improve flock productivity, and strengthen biosecurity infrastructures. Rising threats from highly pathogenic avian influenza, antimicrobial stewardship initiatives, and increasing demand for precision livestock management are accelerating investments in next-generation vaccines, automated hatchery technologies, and advanced veterinary biologics. The market is witnessing a shift away from conventional therapeutic interventions toward preventive, data-driven, and highly scalable disease management approaches that can support large commercial poultry operations while maintaining global disease surveillance standards.
Recombinant Vaccines and DIVA Technologies are Advancing Poultry Disease Prevention
The global poultry vaccine landscape is increasingly centered on multi-disease protection platforms capable of providing broad immunological coverage while preserving epidemiological surveillance capabilities. Recombinant vector vaccines, computational antigen optimization, and hatchery-based immunization strategies are becoming critical components of modern poultry health programs. This trend is exemplified by the commercialization of Boehringer Ingelheim's VAXXITEK HVT+IBD+H5 vaccine, which integrates Computationally Optimized Broadly Reactive Antigen (COBRA) technology to provide cross-clade protection against multiple H5 avian influenza variants while simultaneously targeting Marek's disease and Infectious Bursal Disease. The recombinant Herpesvirus of Turkeys vector architecture also enables Differentiating Infected from Vaccinated Animals (DIVA) functionality, allowing veterinary surveillance programs to distinguish vaccinated flocks from naturally infected populations through serological testing. The deployment of single-dose hatchery vaccination platforms reflects the industry's emphasis on early-life immunity and large-scale operational efficiency.
Precision Hatchery Systems and Next-Generation Biologics are Expanding Poultry Healthcare Capabilities
Automation and advanced biologic manufacturing technologies are becoming increasingly important across commercial poultry production systems. Merck Animal Health's acquisition of TARGAN demonstrates the industry's growing investment in precision hatchery technologies, integrating high-speed computer vision systems capable of sorting up to 160,000 chicks per hour alongside automated ocular vaccine delivery platforms designed for respiratory and coccidiosis prevention. Simultaneously, the veterinary biologics sector is embracing next-generation nucleic acid manufacturing technologies to overcome traditional vaccine production limitations. Ceva Animal Health's collaboration with Touchlight leverages enzymatic doggybone DNA technology to manufacture highly purified linear DNA constructs without bacterial fermentation or antibiotic resistance markers, enabling scalable development of advanced veterinary therapeutics and nucleic acid vaccines. These developments illustrate the broader evolution of poultry medicine toward automated, biologically sophisticated, and highly scalable animal health management platforms.
Poultry Medicine Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities
The global Poultry Medicine market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Zoetis Services LLC, Boehringer Ingelheim International GmbH, Merck & Co., Inc., Elanco Animal Health Incorporated, Phibro Animal Health Corporation, Ceva Sant? Animale, Virbac S.A., Vetoquinol S.A., Huvepharma EOOD, Kyoritsu Seiyaku Corporation. The Poultry Medicine market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Poultry Medicine industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-
Leading companies in Poultry Medicine industry include- Zoetis Services LLC, Boehringer Ingelheim International GmbH, Merck & Co., Inc., Elanco Animal Health Incorporated, Phibro Animal Health Corporation, Ceva Sant? Animale, Virbac S.A., Vetoquinol S.A., Huvepharma EOOD, Kyoritsu Seiyaku Corporation. The Poultry Medicine market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.
What to expect in US Poultry Medicine Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034
The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Poultry Medicine market remains one of the strongest-performing segments in the country.
The US Poultry Medicine Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Poultry Medicine market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Poultry Medicine industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.
Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Poultry Medicine markets
Canada's strong Poultry Medicine sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Poultry Medicine market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.
Germany Poultry Medicine Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.
Germany continues to remain the largest Poultry Medicine market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Poultry Medicine population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Poultry Medicine industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Poultry Medicine market outlook.
France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Poultry Medicine sales through 2034
France Poultry Medicine companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.
UK Poultry Medicine Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain
Small high-need consumer segments remain key priority of Poultry Medicine distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or ?280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was ?49 billion (14.1%) and voluntary health insurance was ?9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.
China Poultry Medicine Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years
China Poultry Medicine market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Poultry Medicine industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Poultry Medicine industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.
India Poultry Medicine Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India
Indian Poultry Medicine market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.
Brazil Poultry Medicine market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities
Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.
Middle East and Africa Poultry Medicine Industry Trends and Perspectives to 2034
According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.
Poultry Medicine Market Segmentation
By Product Type
Vaccines
Pharmaceuticals / Drugs
Medicative Feed Additives
By Animal Type
Chickens
Turkeys
Ducks and Other Poultry Species
By Disease Indication
Viral Diseases
Bacterial Diseases
Parasitic/Fungal Diseases
By Route of Administration
Oral
Parenteral
Topical / Spray / In-Ovo
Leading Companies in Poultry Medicine Industry (2026)
Zoetis Services LLC
Boehringer Ingelheim International GmbH
Merck & Co., Inc.
Elanco Animal Health Incorporated
Phibro Animal Health Corporation
Ceva Sant? Animale
Virbac S.A.
Vetoquinol S.A.
Huvepharma EOOD
Kyoritsu Seiyaku Corporation
Countries Included
The Poultry Medicine market report provides detailed analysis and outlook of Poultry Medicine segments including By Product Type (Vaccines, Pharmaceuticals / Drugs, Medicative Feed Additives), By Animal Type (Chickens, Turkeys, Ducks and Other Poultry Species), By Disease Indication (Viral Diseases, Bacterial Diseases, Parasitic/Fungal Diseases ), By Route of Administration (Oral, Parenteral, Topical / Spray / In-Ovo) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.
Poultry Medicine Industry Overview
Advanced Vaccination Platforms, Hatchery Automation, and Nucleic Acid Technologies are Reshaping the Poultry Medicine Industry
The poultry medicine industry is undergoing rapid technological transformation as producers, veterinary pharmaceutical companies, and regulatory agencies intensify efforts to combat emerging infectious diseases, improve flock productivity, and strengthen biosecurity infrastructures. Rising threats from highly pathogenic avian influenza, antimicrobial stewardship initiatives, and increasing demand for precision livestock management are accelerating investments in next-generation vaccines, automated hatchery technologies, and advanced veterinary biologics. The market is witnessing a shift away from conventional therapeutic interventions toward preventive, data-driven, and highly scalable disease management approaches that can support large commercial poultry operations while maintaining global disease surveillance standards.
Recombinant Vaccines and DIVA Technologies are Advancing Poultry Disease Prevention
The global poultry vaccine landscape is increasingly centered on multi-disease protection platforms capable of providing broad immunological coverage while preserving epidemiological surveillance capabilities. Recombinant vector vaccines, computational antigen optimization, and hatchery-based immunization strategies are becoming critical components of modern poultry health programs. This trend is exemplified by the commercialization of Boehringer Ingelheim's VAXXITEK HVT+IBD+H5 vaccine, which integrates Computationally Optimized Broadly Reactive Antigen (COBRA) technology to provide cross-clade protection against multiple H5 avian influenza variants while simultaneously targeting Marek's disease and Infectious Bursal Disease. The recombinant Herpesvirus of Turkeys vector architecture also enables Differentiating Infected from Vaccinated Animals (DIVA) functionality, allowing veterinary surveillance programs to distinguish vaccinated flocks from naturally infected populations through serological testing. The deployment of single-dose hatchery vaccination platforms reflects the industry's emphasis on early-life immunity and large-scale operational efficiency.
Precision Hatchery Systems and Next-Generation Biologics are Expanding Poultry Healthcare Capabilities
Automation and advanced biologic manufacturing technologies are becoming increasingly important across commercial poultry production systems. Merck Animal Health's acquisition of TARGAN demonstrates the industry's growing investment in precision hatchery technologies, integrating high-speed computer vision systems capable of sorting up to 160,000 chicks per hour alongside automated ocular vaccine delivery platforms designed for respiratory and coccidiosis prevention. Simultaneously, the veterinary biologics sector is embracing next-generation nucleic acid manufacturing technologies to overcome traditional vaccine production limitations. Ceva Animal Health's collaboration with Touchlight leverages enzymatic doggybone DNA technology to manufacture highly purified linear DNA constructs without bacterial fermentation or antibiotic resistance markers, enabling scalable development of advanced veterinary therapeutics and nucleic acid vaccines. These developments illustrate the broader evolution of poultry medicine toward automated, biologically sophisticated, and highly scalable animal health management platforms.
Poultry Medicine Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities
The global Poultry Medicine market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Zoetis Services LLC, Boehringer Ingelheim International GmbH, Merck & Co., Inc., Elanco Animal Health Incorporated, Phibro Animal Health Corporation, Ceva Sant? Animale, Virbac S.A., Vetoquinol S.A., Huvepharma EOOD, Kyoritsu Seiyaku Corporation. The Poultry Medicine market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Poultry Medicine industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-
- Growth Poultry Medicine Market size outlook across 3 scenarios- High growth, reference, and Low growth cases
- Market Trends, Drivers, Potential Opportunities, and Challenges faced by Poultry Medicine companies
- Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry
- Detailed SWOT Analysis of global and regional Poultry Medicine markets
- Competitive analysis including business description, product analysis, and financial profiles
- Key country specific analysis detailing key factors shaping the short-term and long-term outlook
- Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements
Leading companies in Poultry Medicine industry include- Zoetis Services LLC, Boehringer Ingelheim International GmbH, Merck & Co., Inc., Elanco Animal Health Incorporated, Phibro Animal Health Corporation, Ceva Sant? Animale, Virbac S.A., Vetoquinol S.A., Huvepharma EOOD, Kyoritsu Seiyaku Corporation. The Poultry Medicine market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.
What to expect in US Poultry Medicine Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034
The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Poultry Medicine market remains one of the strongest-performing segments in the country.
The US Poultry Medicine Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Poultry Medicine market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Poultry Medicine industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.
Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Poultry Medicine markets
Canada's strong Poultry Medicine sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Poultry Medicine market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.
Germany Poultry Medicine Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.
Germany continues to remain the largest Poultry Medicine market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Poultry Medicine population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Poultry Medicine industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Poultry Medicine market outlook.
France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Poultry Medicine sales through 2034
France Poultry Medicine companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.
UK Poultry Medicine Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain
Small high-need consumer segments remain key priority of Poultry Medicine distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or ?280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was ?49 billion (14.1%) and voluntary health insurance was ?9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.
China Poultry Medicine Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years
China Poultry Medicine market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Poultry Medicine industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Poultry Medicine industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.
India Poultry Medicine Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India
Indian Poultry Medicine market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.
Brazil Poultry Medicine market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities
Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.
Middle East and Africa Poultry Medicine Industry Trends and Perspectives to 2034
According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.
Poultry Medicine Market Segmentation
By Product Type
Vaccines
Pharmaceuticals / Drugs
Medicative Feed Additives
By Animal Type
Chickens
Turkeys
Ducks and Other Poultry Species
By Disease Indication
Viral Diseases
Bacterial Diseases
Parasitic/Fungal Diseases
By Route of Administration
Oral
Parenteral
Topical / Spray / In-Ovo
Leading Companies in Poultry Medicine Industry (2026)
Zoetis Services LLC
Boehringer Ingelheim International GmbH
Merck & Co., Inc.
Elanco Animal Health Incorporated
Phibro Animal Health Corporation
Ceva Sant? Animale
Virbac S.A.
Vetoquinol S.A.
Huvepharma EOOD
Kyoritsu Seiyaku Corporation
Countries Included
- North America- US, Canada, Mexico
- Europe- Germany, France, UK, Spain, Italy, Nordics, Others
- Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others
- Latin America- Brazil, Argentina, Others
- Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
- Get Free print authentication across single, multi, and global licenses
- Free Accompanying excel spreadsheet with complete quantitative data
- Free 2-day consulting support from the lead analyst of the team that developed the report
- Gain clear understanding of current market conditions across 20 countries and plan your decisions accordingly
- Understand competitive profiles of the leading 15 companies in the Electrosurgical Generators industry
- Stay ahead of competition through a detailed analysis of recent market developments
- Make trusted decisions building on our 10-year experience in developing reports on Electrosurgical Generators industry
CHAPTER 1- EXECUTIVE SUMMARY
1.1. Market Snapshot: Market Size, CAGR, and Growth Outlook to 2034
1.2. Key Industry Highlights, 2026
1.3. Premium Market Insights
1.3.1. Potential Poultry Medicine Market Types and Applications
1.3.2. Fastest Growing Countries Over the forecast period
1.4. Market Scope and Segmentation
1.4.1. Key Market Segments
1.4.2. Key Countries and Regions
1.4.3. Top Companies in the Poultry Medicine Industry
1.5. Macroeconomic and Demographic Outlook
1.5.1. GDP Outlook by Top 20 Countries, 2010- 2040
1.5.2. Population Forecast by Country, 2010- 2040
1.5.3. Inflation Trends in Leading Countries
1.6. Impact of Trade Policies, Regulations, and Sustainability
1.6.1. Trade tariffs and localization requirements
1.6.2. ESG and sustainability pressures
1.6.3. Compliance-driven structural changes in the value chain
CHAPTER 2- RESEARCH METHODOLOGY
2.1. Report Coverage
2.2. Secondary Research
2.3. Primary Research
2.4. Data Triangulation
2.5. Market Modeling and Forecasting
CHAPTER 3- GLOBAL POULTRY MEDICINE MARKET TRENDS, GROWTH DRIVERS, CHALLENGES, AND OPPORTUNITIES THROUGH 2034
3.1. An Introduction to Global Poultry Medicine Markets in 2026
3.2. Global Historic and Forecast Poultry Medicine Market Size Outlook, USD Million, 2021- 2034
3.3. Annual Market Size Growth Rate (Y-o-Y), %, 2021-2034
3.4. Market Dynamics
3.4.1. Key Poultry Medicine Market Driving Forces and Their Impact on Market Outlook
3.4.2. Short and Long-Term Trends and Insights Shaping the Future
3.4.3. Potential Poultry Medicine Market Opportunities for Industry Stakeholders
3.4.4. Potential Challenges across Poultry Medicine Value Chain
CHAPTER 4- POULTRY MEDICINE MARKET COMPETITIVE LANDSCAPE, STRATEGIC ANALYSIS, AND VALUE CHAIN ASSESSMENT
4.1. Porter’s Five Forces Analysis
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of Substitutes
4.1.4. Threat of New Entrants
4.1.5. Intensity of Competitive Rivalry
4.1.6. Market Attractiveness Analysis by Segment
4.1.7. Market Attractiveness Analysis by Region
4.2. Competitive Landscape
4.2.1 Market Share Analysis of Leading Poultry Medicine Companies
4.2.2 Recent Strategic Developments
4.2.3 Mergers, Acquisitions, and Partnerships
4.2.4 Product Launches and Innovation Trends
4.2.5 Key Success Factors
4.3. Value Chain Analysis
4.3.1. Key Value Chain Segments
4.3.2. Dominant players by value-chain stage
4.4. SWOT Analysis
4.4.1. Key Strengths and Opportunities
4.4.2. Major Weaknesses and Threats
4.5 Technology Roadmap
4.6 Regulatory and Reimbursement Landscape
CHAPTER 5- POULTRY MEDICINE MARKET OUTLOOK BY SEGMENTS
5.1. Market Size Outlook by Type, USD Million, 2021- 2025 and 2026-2034
5.2. Market Size Outlook by Application, USD Million, 2021- 2025 and 2026-2034
5.3. Market Size Outlook by Country, USD Million, 2021- 2025 and 2026-2034
By Product Type
Vaccines
Pharmaceuticals / Drugs
Medicative Feed Additives
By Animal Type
Chickens
Turkeys
Ducks and Other Poultry Species
By Disease Indication
Viral Diseases
Bacterial Diseases
Parasitic/Fungal Diseases
By Route of Administration
Oral
Parenteral
Topical / Spray / In-Ovo
CHAPTER 6- SCENARIO ANALYSIS AND OUTLOOK
6.1. Base Case Scenario
6.1.1. Definitions and Insights
6.1.2. Market Size Outlook to 2034
6.2. Low Growth Case Scenario
6.2.1. Definitions and Insights
6.2.2. Market Size Outlook to 2034
6.3. High Growth Case Scenario
6.3.1. Definitions and Insights
6.3.2. Market Size Outlook to 2034
CHAPTER 7- NORTH AMERICA POULTRY MEDICINE MARKET SIZE ANALYSIS AND OUTLOOK
7.1. North America Poultry Medicine Market Overview, 2026
7.2. Leading Companies Operating in North America
7.3. Key Industry Statistics, 2026
7.4. North America Poultry Medicine Market Trends and Growth Opportunities to 2034
7.5. North America Poultry Medicine Market Size Outlook by Type
7.6. North America Poultry Medicine Market Size Outlook by Application
7.7. North America Poultry Medicine Market Size Outlook by Country
7.8. United States
7.8.1. Key Statistics
7.8.2. The US Poultry Medicine Market Size Outlook, 2021- 2034
7.8.3. Key Market Drivers and Industry Developments in the US Poultry Medicine Companies
7.9. Canada
7.9.1. Key Statistics
7.9.2. Canada Poultry Medicine Market Size Outlook, 2021- 2034
7.9.3. Key Market Drivers and Industry Developments in Canada Poultry Medicine Companies
7.10. Mexico
7.10.1. Key Statistics
7.10.2. Mexico Poultry Medicine Market Size Outlook, 2021- 2034
7.10.3. Key Market Drivers and Industry Developments in Mexico Poultry Medicine Companies
CHAPTER 8- EUROPE POULTRY MEDICINE MARKET SIZE ANALYSIS AND OUTLOOK
8.1. Europe Poultry Medicine Market Overview, 2026
8.2. Leading Companies Operating in Europe
8.3. Key Industry Statistics, 2026
8.4. Europe Poultry Medicine Market Trends and Growth Opportunities to 2034
8.5. Europe Poultry Medicine Market Size Outlook by Type
8.6. Europe Poultry Medicine Market Size Outlook by Application
8.7. Europe Poultry Medicine Market Size Outlook by Country
8.8. Germany
8.8.1. Key Statistics
8.8.2. Germany Poultry Medicine Market Size Outlook, 2021- 2034
8.8.3. Key Market Drivers and Industry Developments in Germany Poultry Medicine Companies
8.9. France
8.9.1. Key Statistics
8.9.2. France Poultry Medicine Market Size Outlook, 2021- 2034
8.9.3. Key Market Drivers and Industry Developments in France Poultry Medicine Companies
8.10. United Kingdom
8.10.1. Key Statistics
8.10.2. United Kingdom Poultry Medicine Market Size Outlook, 2021- 2034
8.10.3. Key Market Drivers and Industry Developments in the UK Poultry Medicine Companies
8.11. Spain
8.11.1. Key Statistics
8.11.2. Spain Poultry Medicine Market Size Outlook, 2021- 2034
8.11.3. Key Market Drivers and Industry Developments in Spain Poultry Medicine Companies
8.12. Italy
8.12.1. Key Statistics
8.12.2. Italy Poultry Medicine Market Size Outlook, 2021- 2034
8.12.3. Key Market Drivers and Industry Developments in Italy Poultry Medicine Companies
8.13. Rest of Europe
8.13.1. Key Statistics
8.13.2. Rest of Europe Poultry Medicine Market Size Outlook, 2021- 2034
8.13.3. Key Market Drivers and Industry Developments in Rest of Europe Poultry Medicine Companies
CHAPTER 9- ASIA PACIFIC POULTRY MEDICINE MARKET SIZE ANALYSIS AND OUTLOOK
9.1. Asia Pacific Poultry Medicine Market Overview, 2026
9.2. Leading Companies Operating in Asia Pacific
9.3. Key Industry Statistics, 2026
9.4. Asia Pacific Poultry Medicine Market Trends and Growth Opportunities to 2034
9.5. Asia Pacific Poultry Medicine Market Size Outlook by Type
9.6. Asia Pacific Poultry Medicine Market Size Outlook by Application
9.7. Asia Pacific Poultry Medicine Market Size Outlook by Country
9.8. China
9.8.1. Key Statistics
9.8.2. China Poultry Medicine Market Size Outlook, 2021- 2034
9.8.3. Key Market Drivers and Industry Developments in China Poultry Medicine Companies
9.9. Japan
9.9.1. Key Statistics
9.9.2. Japan Poultry Medicine Market Size Outlook, 2021- 2034
9.9.3. Key Market Drivers and Industry Developments in Japan Poultry Medicine Companies
9.10. India
9.10.1. Key Statistics
9.10.2. India Poultry Medicine Market Size Outlook, 2021- 2034
9.10.3. Key Market Drivers and Industry Developments in India Poultry Medicine Companies
9.11. South Korea
9.11.1. Key Statistics
9.11.2. South Korea Poultry Medicine Market Size Outlook, 2021- 2034
9.11.3. Key Market Drivers and Industry Developments in South Korea Poultry Medicine Companies
9.12. Australia
9.12.1. Key Statistics
9.12.2. Australia Poultry Medicine Market Size Outlook, 2021- 2034
9.12.3. Key Market Drivers and Industry Developments in Australia Poultry Medicine Companies
9.13. Southeast Asia
9.13.1. Key Statistics
9.13.2. Southeast Asia Poultry Medicine Market Size Outlook, 2021- 2034
9.13.3. Key Market Drivers and Industry Developments in Southeast Asia Poultry Medicine Companies
CHAPTER 10- SOUTH AND CENTRAL AMERICA POULTRY MEDICINE MARKET SIZE ANALYSIS AND OUTLOOK
10.1. South and Central America Poultry Medicine Market Overview, 2026
10.2. Leading Companies Operating in South and Central America
10.3. Key Industry Statistics, 2026
10.4. South and Central America Poultry Medicine Market Trends and Growth Opportunities to 2034
10.5. South and Central America Poultry Medicine Market Size Outlook by Type
10.6. South and Central America Poultry Medicine Market Size Outlook by Application
10.7. South and Central America Poultry Medicine Market Size Outlook by Country
10.8. Brazil
10.8.1. Key Statistics
10.8.2. Brazil Poultry Medicine Market Size Outlook, 2021- 2034
10.8.3. Key Market Drivers and Industry Developments in Brazil Poultry Medicine Companies
10.9. Argentina
10.9.1. Key Statistics
10.9.2. Argentina Poultry Medicine Market Size Outlook, 2021- 2034
10.9.3. Key Market Drivers and Industry Developments in Argentina Poultry Medicine Companies
10.10. Rest of Latin America
10.10.1. Key Statistics
10.10.2. Rest of Latin America Poultry Medicine Market Size Outlook, 2021- 2034
10.10.3. Key Market Drivers and Industry Developments in Rest of Latin America Poultry Medicine Companies
CHAPTER 11- MIDDLE EAST AND AFRICA POULTRY MEDICINE MARKET SIZE ANALYSIS AND OUTLOOK
11.1. Middle East and Africa Poultry Medicine Market Overview, 2026
11.2. Leading Companies Operating in Middle East and Africa
11.3. Key Industry Statistics, 2026
11.4. Middle East and Africa Poultry Medicine Market Trends and Growth Opportunities to 2034
11.5. Middle East and Africa Poultry Medicine Market Size Outlook by Type
11.6. Middle East and Africa Poultry Medicine Market Size Outlook by Application
11.7. Middle East and Africa Poultry Medicine Market Size Outlook by Country
11.8. Saudi Arabia
11.8.1. Key Statistics
11.8.2. Saudi Arabia Poultry Medicine Market Size Outlook, 2021- 2034
11.8.3. Key Market Drivers and Industry Developments in Saudi Arabia Poultry Medicine Companies
11.9. United Arab Emirates
11.9.1. Key Statistics
11.9.2. The UAE Poultry Medicine Market Size Outlook, 2021- 2034
11.9.3. Key Market Drivers and Industry Developments in the UAE Poultry Medicine Companies
11.10. Africa
11.10.1. Key Statistics
11.10.2. Africa Poultry Medicine Market Size Outlook, 2021- 2034
11.10.3. Key Market Drivers and Industry Developments in Africa Poultry Medicine Companies
CHAPTER 12- COMPANY PROFILES
12.1. Top Companies in Poultry Medicine Industry
Zoetis Services LLC
Boehringer Ingelheim International GmbH
Merck & Co., Inc.
Elanco Animal Health Incorporated
Phibro Animal Health Corporation
Ceva Sant? Animale
Virbac S.A.
Vetoquinol S.A.
Huvepharma EOOD
Kyoritsu Seiyaku Corporation
12.2. Business Description
12.3. SWOT Profiles
12.4. Products and Services
CHAPTER 13- APPENDIX
Glossary of Terms
Research Methodology & Data Sources
Conclusion & Strategic Recommendations
1.1. Market Snapshot: Market Size, CAGR, and Growth Outlook to 2034
1.2. Key Industry Highlights, 2026
1.3. Premium Market Insights
1.3.1. Potential Poultry Medicine Market Types and Applications
1.3.2. Fastest Growing Countries Over the forecast period
1.4. Market Scope and Segmentation
1.4.1. Key Market Segments
1.4.2. Key Countries and Regions
1.4.3. Top Companies in the Poultry Medicine Industry
1.5. Macroeconomic and Demographic Outlook
1.5.1. GDP Outlook by Top 20 Countries, 2010- 2040
1.5.2. Population Forecast by Country, 2010- 2040
1.5.3. Inflation Trends in Leading Countries
1.6. Impact of Trade Policies, Regulations, and Sustainability
1.6.1. Trade tariffs and localization requirements
1.6.2. ESG and sustainability pressures
1.6.3. Compliance-driven structural changes in the value chain
CHAPTER 2- RESEARCH METHODOLOGY
2.1. Report Coverage
2.2. Secondary Research
2.3. Primary Research
2.4. Data Triangulation
2.5. Market Modeling and Forecasting
CHAPTER 3- GLOBAL POULTRY MEDICINE MARKET TRENDS, GROWTH DRIVERS, CHALLENGES, AND OPPORTUNITIES THROUGH 2034
3.1. An Introduction to Global Poultry Medicine Markets in 2026
3.2. Global Historic and Forecast Poultry Medicine Market Size Outlook, USD Million, 2021- 2034
3.3. Annual Market Size Growth Rate (Y-o-Y), %, 2021-2034
3.4. Market Dynamics
3.4.1. Key Poultry Medicine Market Driving Forces and Their Impact on Market Outlook
3.4.2. Short and Long-Term Trends and Insights Shaping the Future
3.4.3. Potential Poultry Medicine Market Opportunities for Industry Stakeholders
3.4.4. Potential Challenges across Poultry Medicine Value Chain
CHAPTER 4- POULTRY MEDICINE MARKET COMPETITIVE LANDSCAPE, STRATEGIC ANALYSIS, AND VALUE CHAIN ASSESSMENT
4.1. Porter’s Five Forces Analysis
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of Substitutes
4.1.4. Threat of New Entrants
4.1.5. Intensity of Competitive Rivalry
4.1.6. Market Attractiveness Analysis by Segment
4.1.7. Market Attractiveness Analysis by Region
4.2. Competitive Landscape
4.2.1 Market Share Analysis of Leading Poultry Medicine Companies
4.2.2 Recent Strategic Developments
4.2.3 Mergers, Acquisitions, and Partnerships
4.2.4 Product Launches and Innovation Trends
4.2.5 Key Success Factors
4.3. Value Chain Analysis
4.3.1. Key Value Chain Segments
4.3.2. Dominant players by value-chain stage
4.4. SWOT Analysis
4.4.1. Key Strengths and Opportunities
4.4.2. Major Weaknesses and Threats
4.5 Technology Roadmap
4.6 Regulatory and Reimbursement Landscape
CHAPTER 5- POULTRY MEDICINE MARKET OUTLOOK BY SEGMENTS
5.1. Market Size Outlook by Type, USD Million, 2021- 2025 and 2026-2034
5.2. Market Size Outlook by Application, USD Million, 2021- 2025 and 2026-2034
5.3. Market Size Outlook by Country, USD Million, 2021- 2025 and 2026-2034
By Product Type
Vaccines
Pharmaceuticals / Drugs
Medicative Feed Additives
By Animal Type
Chickens
Turkeys
Ducks and Other Poultry Species
By Disease Indication
Viral Diseases
Bacterial Diseases
Parasitic/Fungal Diseases
By Route of Administration
Oral
Parenteral
Topical / Spray / In-Ovo
CHAPTER 6- SCENARIO ANALYSIS AND OUTLOOK
6.1. Base Case Scenario
6.1.1. Definitions and Insights
6.1.2. Market Size Outlook to 2034
6.2. Low Growth Case Scenario
6.2.1. Definitions and Insights
6.2.2. Market Size Outlook to 2034
6.3. High Growth Case Scenario
6.3.1. Definitions and Insights
6.3.2. Market Size Outlook to 2034
CHAPTER 7- NORTH AMERICA POULTRY MEDICINE MARKET SIZE ANALYSIS AND OUTLOOK
7.1. North America Poultry Medicine Market Overview, 2026
7.2. Leading Companies Operating in North America
7.3. Key Industry Statistics, 2026
7.4. North America Poultry Medicine Market Trends and Growth Opportunities to 2034
7.5. North America Poultry Medicine Market Size Outlook by Type
7.6. North America Poultry Medicine Market Size Outlook by Application
7.7. North America Poultry Medicine Market Size Outlook by Country
7.8. United States
7.8.1. Key Statistics
7.8.2. The US Poultry Medicine Market Size Outlook, 2021- 2034
7.8.3. Key Market Drivers and Industry Developments in the US Poultry Medicine Companies
7.9. Canada
7.9.1. Key Statistics
7.9.2. Canada Poultry Medicine Market Size Outlook, 2021- 2034
7.9.3. Key Market Drivers and Industry Developments in Canada Poultry Medicine Companies
7.10. Mexico
7.10.1. Key Statistics
7.10.2. Mexico Poultry Medicine Market Size Outlook, 2021- 2034
7.10.3. Key Market Drivers and Industry Developments in Mexico Poultry Medicine Companies
CHAPTER 8- EUROPE POULTRY MEDICINE MARKET SIZE ANALYSIS AND OUTLOOK
8.1. Europe Poultry Medicine Market Overview, 2026
8.2. Leading Companies Operating in Europe
8.3. Key Industry Statistics, 2026
8.4. Europe Poultry Medicine Market Trends and Growth Opportunities to 2034
8.5. Europe Poultry Medicine Market Size Outlook by Type
8.6. Europe Poultry Medicine Market Size Outlook by Application
8.7. Europe Poultry Medicine Market Size Outlook by Country
8.8. Germany
8.8.1. Key Statistics
8.8.2. Germany Poultry Medicine Market Size Outlook, 2021- 2034
8.8.3. Key Market Drivers and Industry Developments in Germany Poultry Medicine Companies
8.9. France
8.9.1. Key Statistics
8.9.2. France Poultry Medicine Market Size Outlook, 2021- 2034
8.9.3. Key Market Drivers and Industry Developments in France Poultry Medicine Companies
8.10. United Kingdom
8.10.1. Key Statistics
8.10.2. United Kingdom Poultry Medicine Market Size Outlook, 2021- 2034
8.10.3. Key Market Drivers and Industry Developments in the UK Poultry Medicine Companies
8.11. Spain
8.11.1. Key Statistics
8.11.2. Spain Poultry Medicine Market Size Outlook, 2021- 2034
8.11.3. Key Market Drivers and Industry Developments in Spain Poultry Medicine Companies
8.12. Italy
8.12.1. Key Statistics
8.12.2. Italy Poultry Medicine Market Size Outlook, 2021- 2034
8.12.3. Key Market Drivers and Industry Developments in Italy Poultry Medicine Companies
8.13. Rest of Europe
8.13.1. Key Statistics
8.13.2. Rest of Europe Poultry Medicine Market Size Outlook, 2021- 2034
8.13.3. Key Market Drivers and Industry Developments in Rest of Europe Poultry Medicine Companies
CHAPTER 9- ASIA PACIFIC POULTRY MEDICINE MARKET SIZE ANALYSIS AND OUTLOOK
9.1. Asia Pacific Poultry Medicine Market Overview, 2026
9.2. Leading Companies Operating in Asia Pacific
9.3. Key Industry Statistics, 2026
9.4. Asia Pacific Poultry Medicine Market Trends and Growth Opportunities to 2034
9.5. Asia Pacific Poultry Medicine Market Size Outlook by Type
9.6. Asia Pacific Poultry Medicine Market Size Outlook by Application
9.7. Asia Pacific Poultry Medicine Market Size Outlook by Country
9.8. China
9.8.1. Key Statistics
9.8.2. China Poultry Medicine Market Size Outlook, 2021- 2034
9.8.3. Key Market Drivers and Industry Developments in China Poultry Medicine Companies
9.9. Japan
9.9.1. Key Statistics
9.9.2. Japan Poultry Medicine Market Size Outlook, 2021- 2034
9.9.3. Key Market Drivers and Industry Developments in Japan Poultry Medicine Companies
9.10. India
9.10.1. Key Statistics
9.10.2. India Poultry Medicine Market Size Outlook, 2021- 2034
9.10.3. Key Market Drivers and Industry Developments in India Poultry Medicine Companies
9.11. South Korea
9.11.1. Key Statistics
9.11.2. South Korea Poultry Medicine Market Size Outlook, 2021- 2034
9.11.3. Key Market Drivers and Industry Developments in South Korea Poultry Medicine Companies
9.12. Australia
9.12.1. Key Statistics
9.12.2. Australia Poultry Medicine Market Size Outlook, 2021- 2034
9.12.3. Key Market Drivers and Industry Developments in Australia Poultry Medicine Companies
9.13. Southeast Asia
9.13.1. Key Statistics
9.13.2. Southeast Asia Poultry Medicine Market Size Outlook, 2021- 2034
9.13.3. Key Market Drivers and Industry Developments in Southeast Asia Poultry Medicine Companies
CHAPTER 10- SOUTH AND CENTRAL AMERICA POULTRY MEDICINE MARKET SIZE ANALYSIS AND OUTLOOK
10.1. South and Central America Poultry Medicine Market Overview, 2026
10.2. Leading Companies Operating in South and Central America
10.3. Key Industry Statistics, 2026
10.4. South and Central America Poultry Medicine Market Trends and Growth Opportunities to 2034
10.5. South and Central America Poultry Medicine Market Size Outlook by Type
10.6. South and Central America Poultry Medicine Market Size Outlook by Application
10.7. South and Central America Poultry Medicine Market Size Outlook by Country
10.8. Brazil
10.8.1. Key Statistics
10.8.2. Brazil Poultry Medicine Market Size Outlook, 2021- 2034
10.8.3. Key Market Drivers and Industry Developments in Brazil Poultry Medicine Companies
10.9. Argentina
10.9.1. Key Statistics
10.9.2. Argentina Poultry Medicine Market Size Outlook, 2021- 2034
10.9.3. Key Market Drivers and Industry Developments in Argentina Poultry Medicine Companies
10.10. Rest of Latin America
10.10.1. Key Statistics
10.10.2. Rest of Latin America Poultry Medicine Market Size Outlook, 2021- 2034
10.10.3. Key Market Drivers and Industry Developments in Rest of Latin America Poultry Medicine Companies
CHAPTER 11- MIDDLE EAST AND AFRICA POULTRY MEDICINE MARKET SIZE ANALYSIS AND OUTLOOK
11.1. Middle East and Africa Poultry Medicine Market Overview, 2026
11.2. Leading Companies Operating in Middle East and Africa
11.3. Key Industry Statistics, 2026
11.4. Middle East and Africa Poultry Medicine Market Trends and Growth Opportunities to 2034
11.5. Middle East and Africa Poultry Medicine Market Size Outlook by Type
11.6. Middle East and Africa Poultry Medicine Market Size Outlook by Application
11.7. Middle East and Africa Poultry Medicine Market Size Outlook by Country
11.8. Saudi Arabia
11.8.1. Key Statistics
11.8.2. Saudi Arabia Poultry Medicine Market Size Outlook, 2021- 2034
11.8.3. Key Market Drivers and Industry Developments in Saudi Arabia Poultry Medicine Companies
11.9. United Arab Emirates
11.9.1. Key Statistics
11.9.2. The UAE Poultry Medicine Market Size Outlook, 2021- 2034
11.9.3. Key Market Drivers and Industry Developments in the UAE Poultry Medicine Companies
11.10. Africa
11.10.1. Key Statistics
11.10.2. Africa Poultry Medicine Market Size Outlook, 2021- 2034
11.10.3. Key Market Drivers and Industry Developments in Africa Poultry Medicine Companies
CHAPTER 12- COMPANY PROFILES
12.1. Top Companies in Poultry Medicine Industry
Zoetis Services LLC
Boehringer Ingelheim International GmbH
Merck & Co., Inc.
Elanco Animal Health Incorporated
Phibro Animal Health Corporation
Ceva Sant? Animale
Virbac S.A.
Vetoquinol S.A.
Huvepharma EOOD
Kyoritsu Seiyaku Corporation
12.2. Business Description
12.3. SWOT Profiles
12.4. Products and Services
CHAPTER 13- APPENDIX
Glossary of Terms
Research Methodology & Data Sources
Conclusion & Strategic Recommendations
